Opinion editor's note: Star Tribune Opinion publishes a mix of national and local commentaries online and in print each day. To contribute, click here.
•••
Republicans in the Florida House have passed a bill authorizing the state to take custody of children if their parents have agreed to give them gender-affirming health care. The law is obviously terrible policy. And it's particularly hypocritical given that conservatives claim to support parental rights in making decisions about children's well-being. The proposed law is also unlawful and certainly unconstitutional.
The reasons why illuminate core questions of government control of our bodies — issues that, in the post-Dobbs era, also come up in the context of abortion rights. Moreover, Florida is hardly alone in attempting to restrict minors' access to gender-affirming care; more than a dozen states have such restrictions, whether by criminalizing the provision of such care (as North Dakota did recently) or by classifying it as child abuse (as Texas tried to do last year).
One problem with the Florida bill is that it overrides regulatory decisions made by the Food and Drug Administration. The drugs known as puberty blockers, which can be used in the treatment of gender-affirming care, have been around for 30 years and are safe and legal when prescribed by a physician. The Florida law is designed to make it impossible to administer those drugs to minors in the state.
Under the principal known as federal preemption, Congress can choose to assume exclusive federal control over regulating a given area, such as nuclear power or pharmaceuticals. Congress exercised that power to make the FDA the sole judge of what drugs are appropriate for medical use and how they should be regulated.
That means the states cannot have their own systems for second-guessing the FDA's judgments. If they could, we would not have a single national pharmaceutical industry, but 50 — controlled by the desires of regulators in 50 different states. There is a relevant comparison here to potential state regulation of mifepristone, the drug used for medical abortions. So far, the issue has not yet been fully adjudicated, but states should not be able to ban the use of a drug approved by the FDA.
Turning to the Constitution, there are at least two provisions that the Florida bill would violate. First, by denying medical care to trans people in particular, the law discriminates. For example, under the bill parents could choose to give puberty blockers to a child experiencing early puberty. The fact that the same parents could not use the same drugs when prescribed by a physician for gender dysphoria shows the unconstitutional double standard.